The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 19.25

Non-Hodgkin Lymphoma

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2016
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to <5 5 to <10 10 to <15 15 to <20 20 to <24 0 to <24b >=24d
All Races Both Sexes 248,946 177,490 117,326 69,109 31,890 644,761 49,943 694,704
Males 135,137 94,173 60,159 36,020 16,581 342,069 25,489 367,558
Females 113,809 83,317 57,167 33,089 15,309 302,692 24,454 327,146
White Both Sexes 213,764 154,454 101,984 60,537 28,026 558,765 49,625 620,368
Males 116,527 82,172 52,535 31,627 14,543 297,404 26,526 330,121
Females 97,237 72,282 49,448 28,910 13,483 261,361 23,099 290,247
Black Both Sexes 20,500 13,640 9,750 5,271 2,215 51,376 4,115 55,491
Males 10,712 7,188 4,768 2,684 1,174 26,526 1,911 28,437
Females 9,789 6,452 4,981 2,587 1,041 24,850 2,204 27,054
Asian/
Pacific
Islander		 Both Sexes 8,405 5,210 3,415 1,867 844 19,741 + +
Males 4,548 2,661 1,757 1,013 407 10,386 + +
Females 3,856 2,549 1,657 855 437 9,355 + +
Hispanic Both Sexes 21,339 14,049 8,272 4,881 2,136 50,676 + +
Males 10,918 7,243 4,331 2,617 1,094 26,202 + +
Females 10,421 6,805 3,941 2,264 1,043 24,474 + +

Estimated prevalence percent a on January 1, 2016, of the SEER population diagnosed in the previous 24 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.2001 0.0035 0.0139 0.0283 0.0538 0.1121 0.2352 0.4640 0.8181 1.0224 0.1738
Males 0.2156 0.0044 0.0189 0.0354 0.0625 0.1293 0.2710 0.5243 0.9364 1.2449 0.2023
Females 0.1850 0.0026 0.0087 0.0208 0.0450 0.0952 0.2010 0.4094 0.7196 0.8856 0.1498
White Both Sexes 0.2216 0.0035 0.0143 0.0289 0.0534 0.1148 0.2427 0.4858 0.8597 1.0738 0.1807
Males 0.2380 0.0045 0.0198 0.0359 0.0622 0.1317 0.2790 0.5442 0.9778 1.3060 0.2095
Females 0.2054 0.0025 0.0085 0.0214 0.0442 0.0976 0.2072 0.4317 0.7593 0.9285 0.1560
Black Both Sexes 0.1139 0.0029 0.0113 0.0265 0.0599 0.1027 0.2010 0.3340 0.5117 0.5333 0.1251
Males 0.1226 0.0029 0.0140 0.0351 0.0696 0.1223 0.2333 0.3969 0.5849 0.6055 0.1457
Females 0.1059 0.0030 0.0086 0.0178 0.0510 0.0853 0.1728 0.2836 0.4608 0.4976 0.1088
Asian/
Pacific
Islander		 Both Sexes 0.0970 0.0039 0.0133 0.0207 0.0353 0.0680 0.1409 0.2692 0.4470 0.6094 0.1032
Males 0.1065 0.0044 0.0175 0.0240 0.0398 0.0744 0.1640 0.3072 0.5516 0.7472 0.1222
Females 0.0882 0.0033 0.0092 0.0175 0.0312 0.0623 0.1209 0.2384 0.3629 0.5207 0.0880
Hispanic Both Sexes 0.0887 0.0030 0.0117 0.0206 0.0398 0.0850 0.1769 0.3632 0.5888 0.7209 0.1294
Males 0.0908 0.0035 0.0147 0.0256 0.0455 0.0932 0.1924 0.3940 0.6326 0.8003 0.1420
Females 0.0866 0.0024 0.0086 0.0151 0.0337 0.0766 0.1616 0.3360 0.5552 0.6719 0.1185

Footnotes:

a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2016 US population estimates based on the average of 2015 and 2016 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years.

b Maximum limited-duration prevalence is 24 years for 1992-2016 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing 0 to <24 and >=24.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.